Related Experiment Video
Updated: Jun 10, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Significant publications on infectious diseases pharmacotherapy in 2009
Hannah R Palmer1, Jessica M Cottreau, Kevin W Garey
1St. Luke's Episcopal Hospital, Houston, TX, USA.
Insights
This review highlights key 2009 publications impacting infectious diseases (ID) pharmacotherapy. Experts identified top articles to help clinicians stay current with essential ID drug therapy advancements.
Area of Science:
- Pharmacotherapy
- Infectious Diseases
- Medical Literature Review
Background:
- The rapid growth of publications in infectious diseases (ID) pharmacotherapy makes it challenging for professionals to stay updated.
- Identifying significant contributions to the field is crucial for advancing pharmacy practice.
Purpose of the Study:
- To summarize significant publications in infectious diseases (ID) pharmacotherapy from 2009.
- To assist healthcare professionals in staying abreast of critical advancements in ID drug therapy.
Main Methods:
- A survey was distributed to members of the Society of Infectious Diseases Pharmacists (SIDP).
- Respondents identified the most impactful articles from a curated list of 2009 publications.
- Articles were categorized into HIV-related and non-HIV-related groups.
Main Results:
- 100 out of 531 SIDP members responded to the survey (18.8% response rate).
- The survey identified the top 10 most significant publications impacting ID pharmacotherapy in 2009 (9 non-HIV, 1 HIV-related).
- Three of the top non-HIV articles were new or updated ID guidelines.
Conclusions:
- This review consolidates essential ID pharmacotherapy literature, reducing the burden on practitioners.
- The identified articles represent critical advancements in infectious diseases drug therapy for 2009.
- Staying informed on key publications is vital for evidence-based pharmacy practice in ID.
Purpose:
Significant publications on infectious diseases (ID) pharmacotherapy in 2009 are summarized.
Summary:
On December 31, 2009, the Houston Infectious Diseases Network amassed a list of articles identified as having a significant impact on ID pharmacotherapy. Articles selected were published between January 1, 2009, and December 31, 2009, in prominent, peer-reviewed journals. Articles were selected based on their perceived potential impact on pharmacy practice in ID, human immunodeficiency virus (HIV), or acquired immune deficiency syndrome (AIDS). A list of 45 articles not related to HIV infection and 17 articles related to HIV infection was distributed to members of the Society of Infectious Diseases Pharmacists (SIDP) via an Internet survey. Members were asked to select the 10 publications (from the list of 45 non-HIV-related articles) that they felt contributed most to ID pharmacotherapy and to select the single most significant publication from the list of 17 articles related to HIV or AIDS. Of the 531 SIDP members surveyed, 100 responded (18.8%). The top 10 articles (9 non-HIV-related and 1 HIV-related) identified from this survey are summarized in this article. Three of the top 10 articles selected from the non-HIV category included new or updated ID guidelines. Summaries of the top articles selected (9 non-HIV-related and 1 HIV-related) from this survey are included.
Conclusion:
Due to the growing number of articles published each year, it is difficult to maintain a current knowledge of significant publications in ID. This review of significant publications in ID pharmacotherapy can be helpful by lessening this burden.
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Microorganisms in Medicine and Therapeutics
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Inhibitors of Viral Protein Synthesis
Endocarditis III: Medical Management
